False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake

被引：6
|
作者：
Hartrampf, Philipp E. [1 ]
Seitz, Anna Katharina [2 ]
Krebs, Markus [2 ,3 ]
Buck, Andreas K. [1 ]
Lapa, Constantin [1 ,4 ]
机构：
[1] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Urol & Paediat Urol, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[4] Univ Hosp Augsburg, Dept Nucl Med, Augsburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 08期
关键词：
Liver; -; Urology;
D O I：
10.1007/s00259-019-04645-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：2044 / 2046
页数：3
相关论文
共 50 条
  • [41] Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
    Hvittfeldt, Erland
    Bjoersdorff, Mimmi
    Brolin, Gustav
    Minarik, David
    Svegborn, Sigrid L.
    Oddstig, Jenny
    Tragardh, Elin
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2022, 42 (06) : 443 - 452
  • [42] Hurthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT
    Tang, Kun
    Wang, Zhiqiang
    Lin, Jie
    Zheng, Xiangwu
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (03) : 223 - 224
  • [43] 18F-PSMA-1007 PET/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report
    Wang, Long
    Tang, Yongxiang
    Yin, Hongling
    Hu, Shuo
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (02) : 991 - 996
  • [44] 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer
    Liu, Bo-Le
    Hong, Jun-Jie
    Tang, Kun
    Lin, Jie
    Zheng, Xiang-Wu
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E355 - E357
  • [45] A Comparison of 18F-PSMA-1007 and 64Cu-PSMA in 2 Patients With Metastatic Prostate Cancer
    Cardoza-Ochoa, David R.
    Rivera-Bravo, Belen
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E120 - E122
  • [46] Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
    Mittlmeier, Lena M.
    Brendel, Matthias
    Beyer, Leonie
    Albert, Nathalie L.
    Todica, Andrei
    Zacherl, Mathias J.
    Wenter, Vera
    Herlemann, Annika
    Kretschmer, Alexander
    Ledderose, Stephan T.
    Schmidt-Hegemann, Nina-Sophie
    Kunz, Wolfgang G.
    Ricke, Jens
    Bartenstein, Peter
    Ilhan, Harun
    Unterrainer, Marcus
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
    Zhou, Xing
    Jiang, Xiao
    Liu, Luzhou
    Wang, Xiaoxiong
    Li, Chuan
    Yao, Yutang
    Kou, Ying
    Shen, Jiaqi
    Shen, Taipeng
    Li, Zeng
    Yang, Shengke
    Zhou, Shukui
    Liao, Hong
    Luo, Zhifu
    Wu, Xiaoai
    Chen, Shirong
    Cheng, Zhuzhong
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [48] 18F-PSMA-1007 PET/MR value for the detection of bone metastasis in prostate cancer
    Xu, Yuanfan
    Wang, Fangxiao
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [49] The Value of 18F-PSMA-1007 PET/CT in Predicting Pathological Upgrading and Downgrading of Newly Diagnosed Prostate Cancer
    Zheng, Anqi
    Wang, Zhuonan
    Luo, Liang
    Chang, Ruxi
    Gao, Jungang
    Wang, Bo
    Duan, Xiaoyi
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [50] The value of 18F-PSMA-1007 PET/CT in preoperative evaluation of prostate cancer within PSA gray area
    Bian, Shuying
    Wang, Meihao
    Yao, Fei
    Zhu, Dongqin
    Pan, Kehua
    Yang, Yunjun
    Tang, Kun
    Hong, Weifeng
    Ji, Xiaowei
    JOURNAL OF MENS HEALTH, 2023, 20 (08) : 109 - 117
12345